Avantor (AVTR) Set to Announce Earnings on Friday

Avantor (NYSE:AVTR) will post its quarterly earnings results before the market opens on Friday, October 25th. Analysts expect Avantor to post earnings of $0.25 per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

Avantor (NYSE:AVTR) last posted its earnings results on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.02. The firm had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.70 billion. Avantor had a return on equity of 12.40% and a net margin of 5.28%. On average, analysts expect Avantor to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Avantor Stock Performance

AVTR stock opened at $23.72 on Thursday. The business’s 50-day moving average price is $25.59 and its two-hundred day moving average price is $24.30. The company has a current ratio of 1.59, a quick ratio of 1.05 and a debt-to-equity ratio of 0.89. The firm has a market cap of $16.11 billion, a PE ratio of 60.82, a P/E/G ratio of 2.93 and a beta of 1.33. Avantor has a 1-year low of $16.63 and a 1-year high of $28.00.

Insider Buying and Selling at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total value of $88,336.50. Following the sale, the chief accounting officer now owns 29,544 shares in the company, valued at $740,372.64. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.50% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on AVTR. Evercore ISI dropped their price target on Avantor from $28.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 2nd. Morgan Stanley lifted their price target on Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Stifel Nicolaus lifted their price target on Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Barclays lifted their price target on Avantor from $25.00 to $28.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Finally, TD Cowen lifted their price target on Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Three research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $28.00.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.